Share
Clinical Nutrition Market: By Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Others); By End User (Pediatric, Adults and Geriatric), And Region – Global Analysis of Market Size, Share & Trends For 2019–2020 And Forecasts To 2031
Clinical Nutrition Market to surpass USD 27.16 billion by 2031 from USD 14.13 billion in 2021 at a CAGR of 6.4% in the coming years, i.e., 2021-31.
Clinical nutrition product is a type of pharmaceutical product that aids in the maintenance of a patient's health. It contributes to the improvement of the metabolic system by providing adequate supplements such as minerals, vitamins, and other nutrients. Clinical nutrition diagnoses and treats diseases that affect the intake, intestinal absorption, and metabolism of dietary constituents, as well as promotes health through diet-related disease prevention. It is applicable in both acute and ambulatory care settings, such as cardiac rehabilitation, renal dialysis, diabetes, paediatrics, nutrition support, cancer, trauma, wellness centres, and community-based intervention programmes.
Global Clinical Nutrition Market to surpass USD 27.16 billion by 2031 from USD 14.13 billion in 2021 at a CAGR of 6.4% in the coming years, i.e., 2021-31. The rise in the prevalence of metabolic disorders, high healthcare spending, and the rise of the middle class in emerging economies are driving the global clinical nutrition market's growth. Furthermore, the growing elderly population and the development of clinical nutrition products tailored to the needs of the elderly are expected to fuel market growth.
Based on application, global Clinical Nutrition Market is fragmented into Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Others. During the forecasted period, cancer held the largest market share. The growing geriatric population base, combined with an increase in the number of people suffering from chronic conditions such as cancer and diabetes, is expected to drive the market over the forecast timeframe. The rising prevalence of chronic diseases has prompted an increase in clinical nutrition prescriptions, as patients suffering from such conditions are deficient in a number of essential nutrients. Furthermore, the growing obesity population as a result of poor dietary habits and physical inactivity will drive industry growth.
Global Clinical Nutrition Market is classified on the basis of end user into Pediatric, Adults and Geriatric. In the forecasted period, the pediatric segment is expected to grow at a rapid pace due to rising malnutrition rates and preterm birth rates worldwide.
Poverty and overpopulation are two other factors that contribute to the spread of malnutrition in developing countries.
Rising prevalence of chronic diseases and poverty
The rising prevalence of chronic diseases such as cancer and cardiovascular disorders, malnutrition, respiratory diseases, and gastrointestinal diseases among children and adults is contributing to an increase in the demand for nutritional assistance. Malnutrition, micronutrient deficiency, and dehydration are common in patients suffering from neurological diseases. Multiple sclerosis, Parkinson's disease, and oropharyngeal dysphagia are a few examples of such neurological ailments. Oropharyngeal dysphagia, which is most common in the elderly population, is also common in dementia patients. Poverty and overpopulation are two other factors that contribute to the spread of malnutrition in developing countries.
Research and Development
Increase in research and development is expected to spur growth in clinical nutrition market. Companies are implementing collaborative business tactics to boost efficiency, supply consumers with high-quality products, and extend their geographical presence.
Lack of awareness and stringent government regulations
Lack of awareness, particularly in developing countries, and stringent government regulations are just a few of the constraints that may lead to a lower adoption of alternative nutrition methods. Clinical nutrition market growth may be hampered in the world's least developed regions, where living standards are lower, due to a refusal of rationalised means of consuming nutrition and a lack of acceptance of newer approaches.
(Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
Global Clinical Nutrition Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America accounted for the largest share and is expected to maintain its dominance due to high R&D spending, the presence of major players and their product availability, and the region's well-established healthcare infrastructure. However, Asia-Pacific is expected to have the highest CAGR during the forecast period, as Asian governments invest in healthcare infrastructure development.
The COVID-19 pandemic is expected to have a significant impact on the clinical nutrition products market, as the demand for nutritional management, particularly among children and the elderly, continues to rise. The demand for clinical nutrition products is increasing as consumers seek various immunity-boosting alternatives to avoid becoming infected with the novel coronavirus. The infection also causes a loss of appetite, as well as other symptoms like anosmia dysgeusia or diarrhoea, which both increase the risk of disease-related malnutrition.
|
Report Attribute |
Details |
|
Market size value in 2021 |
USD 14.13 billion |
|
Revenue forecast in 2031 |
USD 27.16 billion |
|
Growth Rate |
CAGR of 6.4% from 2021 to 2031 |
|
Base year for estimation |
2021 |
|
Quantitative units |
Revenue in USD million and CAGR from 2021 to 2031 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
End user, Application and Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
|
Key companies profiled |
Nestle SA, Baxter International Inc, Abbott Laboratories, Braun Melsungen AG, GroupeDanone, Mead Johnson Nutrition Company, Fresenius Kabi AG, Hospira Inc, Perrigo Company Plc and Other Prominent Players. |
Global Clinical Nutrition Market to surpass USD 27.16 billion by 2031 from USD 14.13 billion in 2021 at a CAGR of 6.4% in the coming years, i.e., 2021-31.
A clinical nutrition product is a type of pharmaceutical product that aids in the maintenance of a patient's health. It contributes to the improvement of the metabolic system by providing adequate supplements such as minerals, vitamins, and other nutrients. Clinical nutrition diagnoses and treats diseases that affect the intake, intestinal absorption, and metabolism of dietary constituents, as well as promotes health through diet-related disease prevention.
During the forecasted period, cancer and pediatric segment held the largest market share.
Nestle SA, Baxter International Inc, Abbott Laboratories, Braun Melsungen AG, GroupeDanone
The rise in the prevalence of metabolic disorders, high healthcare spending, and the rise of the middle class in emerging economies are driving the global clinical nutrition market's growth. Furthermore, the growing elderly population and the development of clinical nutrition products tailored to the needs of the elderly are expected to fuel market growth.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
